Xenon Pharmaceuticals Inc (XENE) financials · rev $7.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Xenon Pharmaceuticals Inc (XENE) rev $7.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $7.50M | N/A |
| Operating Income | -$373.1M | -$279.3M |
| Net Income | -$345.9M | -$234.3M |
| EPS (Diluted) | -$4.36 | -$3.01 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $633.2M | $798.1M |
| Current Assets | $560.6M | $635.3M |
| Cash & Equivalents | $199.2M | $142.7M |
| PP&E | $8.72M | $10.3M |
| Total Liabilities | $51.4M | $43.2M |
| Current Liabilities | $41.8M | $35.6M |
| Shareholders' Equity | $581.8M | $754.9M |
| Retained Earnings | -$1.25B | -$899.5M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$279.1M | -$181.4M |
| CapEx | $799.0K | $3.08M |
| Investing Cash Flow | $218.0M | $165.0M |
| Financing Cash Flow | $117.1M | $12.1M |
| Net Change in Cash | $56.5M | -$5.93M |
| Free Cash Flow | -$279.9M | -$184.5M |
FAQ
What is XENE P/E and revenue?
Xenon Pharmaceuticals Inc (XENE) rev $7.5M.
What is XENE revenue?
Xenon Pharmaceuticals Inc last cached revenue is $7.50M (FY2025).
Is XENE profitable?
Xenon Pharmaceuticals Inc last cached net income is -$345.9M (FY2025).
What are XENE total assets?
Xenon Pharmaceuticals Inc last cached total assets are $633.2M (FY2025).
What is XENE free cash flow?
Xenon Pharmaceuticals Inc last cached free cash flow is -$279.9M (FY2025).
Not investment advice. Cached statements, not a live tape.